Home
Stock
ETF
Institutional Holdings
Compound interest
Blog
Support Me
Login
Join us
Français
English
NASDAQ
/
Healthcare
/
Biotechnology
/
SPRO
Spero Therapeutics, Inc.
SPRO
Summary
30-Y Financials
Dividend
Analyst
Peer analysis
Key metrics
Ownership / Senat
Dividend historical
Dividend payout ratio
0.00
%
Dividend split
Date
Split
